ScinoPharm Taiwan Ltd (1789) — Cash Flow-to-Debt Ratio
ScinoPharm Taiwan Ltd (1789) has a Cash Flow-to-Debt Ratio of 0.13x as of March 2026, meaning its operating cash flow of NT$199.47 Million could theoretically repay 0% of its total liabilities (NT$1.55 Billion) in one year. See ScinoPharm Taiwan Ltd free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
ScinoPharm Taiwan Ltd Cash Flow-to-Debt Ratio (2007–2025)
Historical debt coverage capacity for ScinoPharm Taiwan Ltd across 19 annual periods. For the full cash flow conversion analysis, see ScinoPharm Taiwan Ltd operating cash flow efficiency.
Annual Cash Flow-to-Debt Ratio for ScinoPharm Taiwan Ltd (2007–2025)
Year-by-year debt coverage analysis for ScinoPharm Taiwan Ltd. Check how high is ScinoPharm Taiwan Ltd's earnings quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (TWD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.45x | NT$597.11 Million | NT$1.33 Billion | ▼ -15.5% |
| 2024 | 0.53x | NT$750.91 Million | NT$1.42 Billion | ▲ +211.2% |
| 2023 | 0.17x | NT$231.13 Million | NT$1.36 Billion | ▼ -67.8% |
| 2022 | 0.53x | NT$773.79 Million | NT$1.46 Billion | ▲ +22.6% |
| 2021 | 0.43x | NT$509.82 Million | NT$1.18 Billion | ▼ -39.9% |
| 2020 | 0.72x | NT$946.31 Million | NT$1.32 Billion | ▲ +28.8% |
| 2019 | 0.56x | NT$788.95 Million | NT$1.41 Billion | ▼ -8.3% |
| 2018 | 0.61x | NT$1.23 Billion | NT$2.02 Billion | ▲ +43.0% |
| 2017 | 0.43x | NT$971.71 Million | NT$2.28 Billion | ▼ -34.7% |
| 2016 | 0.65x | NT$1.67 Billion | NT$2.56 Billion | ▲ +47.5% |
| 2015 | 0.44x | NT$1.04 Billion | NT$2.36 Billion | ▼ -1.0% |
| 2014 | 0.45x | NT$888.29 Million | NT$1.99 Billion | ▼ -12.6% |
| 2013 | 0.51x | NT$939.47 Million | NT$1.84 Billion | ▼ -34.0% |
| 2012 | 0.77x | NT$981.55 Million | NT$1.27 Billion | ▼ -45.0% |
| 2011 | 1.41x | NT$1.29 Billion | NT$920.78 Million | ▼ -44.2% |
| 2010 | 2.52x | NT$1.56 Billion | NT$620.97 Million | ▲ +162.4% |
| 2009 | 0.96x | NT$1.30 Billion | NT$1.35 Billion | ▲ +58.3% |
| 2008 | 0.61x | NT$1.41 Billion | NT$2.32 Billion | ▲ +273.0% |
| 2007 | 0.16x | NT$504.50 Million | NT$3.10 Billion | — |